# Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

> **NCT01347801** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 40 (actual)

## Conditions studied

- Hypoglycaemia

## Interventions

- **DRUG:** GLP-1
- **DRUG:** Placebo (Saline)
- **DRUG:** TNF-alfa
- **OTHER:** OGTT
- **OTHER:** IVGTT

## Key facts

- **NCT ID:** NCT01347801
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347801, "Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01347801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*